news > company > article

isoSolutions Announces New Managing Director and Strategic Consultant

David T. DrummondPosted by David T. Drummond ⎜ Oct 2, 2020 ⎜ Company

isoSolutions Marketing and Management Inc. announces that Mr. David Drummond, Founder, and Managing Director, has decided to retire from the routine affairs of the company. He will continue to participate in the company as Strategic Consultant and President. The company is pleased to announce that Mr. Arun Kumar Singh, MSc MBA CSSMBB MCPM PMP, has replaced Mr. Drummond as Managing Director of isoSolutions. The owner of isoSolutions, Mr. Mark McCooey, stated: “isoSolutions remains committed to all of the business values instilled by David over the years of exemplary service. I am pleased Arun has joined isoSolutions and am confident that he will lead the company into an exciting future.”

In David’s new position as Strategic Consultant and President, he will continue to guide isoSolutions on strategic initiatives based on his extensive experience gained through his involvement in the nuclear medicine industry for more than forty years. When he founded isoSolutions, he brought to the company his experience in Canada, Europe, and the United States, and a network of suppliers and users of many nuclear medicine products. Since then, the company has added qualified and motivated staff and established a unique resource of high-quality suppliers, which serve its customers in the primary markets of Canada, the United States, Latin America, and Asia.

Mr. Arun Kumar Singh, MSc MBA CSSMBB MCPM PMP, who replaces Mr. Drummond as Managing Director of isoSolutions, has worked for more than 20 years in the Healthcare delivery (Pharmaceuticals, Hospitals, Radiopharmaceuticals, Life Sciences) and Coatings industries. His educational background includes a Masters in Organic Chemistry and MBA. As a certified Six Sigma Master Black Belt, he has worked extensively on business process optimization using Lean Six Sigma and other methodologies. As Project Manager for Montreal based Jubilant DraxImage Inc., he led a portfolio of New Product Introduction projects encompassing concept to launch of Radiopharmaceutical products, including Ruby-Fill ®, Drax Exametazime®. Prior to joining isoSolutions, Arun worked briefly for Baxter Corporation. Work experiences with multinational organizations have uniquely prepared him to play a key role in the long term growth of isoSolutions.

The owner of isoSolutions, Mr. Mark McCooey, stated: “isoSolutions remains committed to all of the business values instilled by David over the years of exemplary service to our customers. We will continue to negotiate fairly and honestly in all contract matters, deliver our time-sensitive products on schedule, and maintain open discussions with both customers and suppliers to increase sales in all of our emerging markets. David’s expertise remains available to all of our customers and suppliers during the transition. I am pleased Arun has joined isoSolutions and am confident that he will lead the company into an exciting future.”

David Drummond confirmed: “With the addition of Arun Singh, isoSolutions is in good hands as we move into the future and continue to grow our business. I am pleased to support the transition to a new leader; contribute to new strategic projects; and continue the strong relationship with long-time suppliers and customers.”

Arun Singh added: “I’m extremely pleased to join the isoSolutions team and impressed by our ability to deliver products to customers across the globe. I’m looking forward to collaborating with our partners to continue to deliver these critical life-saving products in the most effective and efficient way. We will work with our valued partners to ensure nuclear medicine products are delivered across the globe, thereby enhancing value for all stakeholders and providing better access to the patients who matter the most.


About isoSolutions Marketing & Management Inc.


More information on the company can be found at www.isosolutions.com.